Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care

May-16

Cardiovascular Nephrology

AUTHORS : Alexander Michel, Epidemiology, Bayer Pharma AG, 13342 Berlin, Germany – Email: alexander.michel@bayer.com

JOURNAL : BMC Family Practice

REFERENCE: 17:51

DOI : 10.1186/s12875-016-0448-5

Read more